The 10-second takeaway
For the quarter ended Sep. 30 (Q3), WebMD Health beat expectations on revenues and exceeded expectations on earnings per share.
Compared to the prior-year quarter, revenue contracted and GAAP earnings per share shrank to a loss.
Margins dropped across the board.
WebMD Health reported revenue of $117.5 million. The seven analysts polled by S&P Capital IQ expected revenue of $114.3 million on the same basis. GAAP reported sales were 13% lower than the prior-year quarter's $135.1 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
EPS came in at -$0.06. The six earnings estimates compiled by S&P Capital IQ predicted -$0.09 per share. GAAP EPS were -$0.02 for Q3 against $0.24 per share for the prior-year quarter.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the quarter, gross margin was 54.6%, 910 basis points worse than the prior-year quarter. Operating margin was 1.3%, 1,860 basis points worse than the prior-year quarter. Net margin was -0.8%, 1,130 basis points worse than the prior-year quarter.
Next quarter's average estimate for revenue is $125.4 million. On the bottom line, the average EPS estimate is $0.00.
Next year's average estimate for revenue is $460.9 million. The average EPS estimate is -$0.36.
The stock has a two-star rating (out of five) at Motley Fool CAPS, with 110 members out of 165 rating the stock outperform, and 55 members rating it underperform. Among 47 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 32 give WebMD Health a green thumbs-up, and 15 give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on WebMD Health is hold, with an average price target of $15.67.
Internet software and services are being consumed in radically different ways, on new and increasingly mobile devices. Is WebMD Health on the right side of the revolution? Check out the changing landscape and meet the company that Motley Fool analysts expect to lead "The Next Trillion-dollar Revolution." Click here for instant access to this free report.
- Add WebMD Health to My Watchlist.
Seth Jayson had no position in any company mentioned here at the time of publication. You can view his stock holdings here. He is co-advisor of Motley Fool Hidden Gems, which provides new small-cap ideas every month, backed by a real-money portfolio. The Motley Fool has no positions in the stocks mentioned above. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.